X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $430,000 | -5.7% | 66,888 | -0.8% | 0.01% | -14.3% |
| Q3 2020 | $456,000 | -77.5% | 67,423 | -69.0% | 0.01% | -77.4% |
| Q2 2020 | $2,026,000 | -38.0% | 217,423 | -33.5% | 0.03% | -52.3% |
| Q1 2020 | $3,269,000 | -9.6% | 326,902 | -3.3% | 0.06% | +35.4% |
| Q4 2019 | $3,618,000 | +468.9% | 338,094 | +576.2% | 0.05% | +433.3% |
| Q3 2019 | $636,000 | -15.2% | 50,000 | 0.0% | 0.01% | -10.0% |
| Q2 2019 | $750,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |